An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Ng, Sophia ^a   Wu, Peng ^a   Nishiura, Hiroshi ^a,b   Ip, Dennis K M ^a   Lee, Esther S T ^a   Cowling, Benjamin J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Influenza; Pandemic; Seasonal; Subsidy; Target groups; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; INTERNET; MAJOR CLINICAL STUDY; NATIONAL HEALTH INSURANCE; NURSING HOME PATIENT; NURSING HOME PERSONNEL; OBESITY; OCCUPATION; POLICY; PREGNANCY; PRESCHOOL CHILD; REIMBURSEMENT; SCHOOL CHILD; ANIMAL; DISEASE TRANSMISSION; FEMALE; HEALTH CARE POLICY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEWBORN; ORTHOMYXOVIRUS; PANDEMIC; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH POLICY; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; PANDEMICS; PREGNANCY; YOUNG ADULT;

EID: 80052035040     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-230     Document Type: Article

References (37)

1. Heinonen S, Silvennoinen H, Lehtinen P, Vainionpaa R, Ziegler T, Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 2011, 11(1):23-29. 10.1016/S1473-3099(10)70255-3, 21106443.
2. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008, (2):CD004879.
3. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010, (7):CD001269.
4. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186. 10.1001/jama.289.2.179, 12517228.
5. Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, Black S, Shay DK. Influenza- and RSV-associated hospitalizations among adults. Vaccine 2007, 25(5):846-855. 10.1016/j.vaccine.2006.09.041, 17074423.
6. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, (2):CD004876.
7. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361(20):1945-1952. 10.1056/NEJMoa0906453, 19745214.
8. Schwartz B, Orenstein WA. Prioritization of pandemic influenza vaccine: rationale and strategy for decision making. Curr Top Microbiol Immunol 2009, 333:495-507. 10.1007/978-3-540-92165-3_24, 19768421.
9. Straetemans M, Buchholz U, Reiter S, Haas W, Krause G. Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review. BMC Public Health 2007, 7:236. 10.1186/1471-2458-7-236, 2048949, 17825095.
10. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, et al. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill 2008, 13(43):pii: 19017.
11. Pan American Health Organization Report on the progress of pandemic influenza (H1N1) vaccination in Latin America and the Caribbean (LAC). 2010, Pan American Health Organization.
12. Pan American Health Organization Report on the progress of pandemic influenza (H1N1) vaccination in the region of the Americas. 2010, Pan American Health Organization.
13. The World Bank Data: countries and economies. (accessed 10-05-2011), The World Bank., http://data.worldbank.org/country
14. Gwet KL, . (ed.) Handbook of Inter-rater Reliability 2010, Gaithersburg, MD, USA: Advanced Analytics, second, (ed.).
15. World Health Organization Pandemic (H1N1) 2009 vaccine deployment update. (accessed 10-05-2011), World Health Organization., http://www.who.int/csr/disease/swineflu/h1n1_vaccine_deployment_update20100927.pdf
16. Wallinga J, van Boven M, Lipsitch M. Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci USA 2010, 107(2):923-928. 10.1073/pnas.0908491107, 2818907, 20080777.
17. Longini IM, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol 2005, 161(4):303-306. 10.1093/aje/kwi053, 15692073.
18. Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science 2009, 325(5948):1705-1708. 10.1126/science.1175570, 19696313.
19. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009, 326(5953):729-733. 10.1126/science.1177373, 2880578, 19745114.
20. Longini IM, Ackermana E, Elveback LR. An optimization model for influenza A epidemics. Math Biosci 1978, 38(1-2):141-157.
21. Centers for Disease Control and Prevention 2009 Pandemic Influenza A (H1N1) Virus Infections - Chicago, Illinois, April-July 2009. Morb Mortal Wkly Rep 2009, 58(33):913-918. Centers for Disease Control and Prevention.
22. Matrajt L, Longini IM. Optimizing vaccine allocation at different points in time during an epidemic. PLoS One 2010, 5(11):e13767.. 2978681, 21085686.
23. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, Shen AL, Ho A, Hung IF, Riley S, Ho LM, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010, 51(10):1184-1191. 10.1086/656740, 20964521.
24. Centers for Disease Control and Prevention 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care - New York City, 2009. Morb Mortal Wkly Rep 2010, 59(11):321-326. Centers for Disease Control and Prevention.
25. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Lindstrom S, Louie JK, Christ CM, Bohm SR, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374(9688):451-458. 10.1016/S0140-6736(09)61304-0, 19643469.
26. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302(17):1896-1902. 10.1001/jama.2009.1583, 19887665.
27. . The ANZIC Influenza Investigators, Australasian Maternity Outcomes Surveillance System Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ 2010, 340:c1279. 2841744, 20299694, The ANZIC Influenza Investigators, Australasian Maternity Outcomes Surveillance System.
28. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol 2006, 107(6):1315-1322. 10.1097/01.AOG.0000218702.92005.bb, 16738158.
29. Mullooly JP, Barker WH, Nolan TF. Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep 1986, 101(2):205-211. 1477788, 3083477.
30. Irving WL, James DK, Stephenson T, Laing P, Jameson C, Oxford JS, Chakraverty P, Brown DW, Boon AC, Zambon MC. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 2000, 107(10):1282-1289. 10.1111/j.1471-0528.2000.tb11621.x, 11028582.
31. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361(20):1935-1944. 10.1056/NEJMoa0906695, 19815859.
32. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, Belay B, Jain S, Cox C, Kamimoto L, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010, 5(3):e9694.. 2837749, 20300571.
33. Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B, Wang Y, Wang W, Kang J, Liu P. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis 2010, 10:145. 10.1186/1471-2334-10-145, 2890005, 20513239.
34. Zhou Y, Ng DMW, Seto W-H, Ip DKM, Kwok HKH, Ma ESK, Ng S, Lau LLH, Wu JT, Peiris JSM, et al. Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J Hosp Infect 2011,
35. Seto W-H, Cowling BJ, Ching H-SLPTY, To M-L, Pittet D. Clinical and Non-Clinical Healthcare Workers Faced a Similar Risk of Acquiring 2009 Pandemic H1N1 Infection. Clin Infect Dis 2011,
36. Helms CM, Polgreen PM. Should influenza immunisation be mandatory for healthcare workers? Yes. BMJ 2008, 337:a2142. 10.1136/bmj.a2142, 18957466.
37. Isaacs D, Leask J. Should influenza immunisation be mandatory for healthcare workers? No. BMJ 2008, 337:a2140. 10.1136/bmj.a2140, 18957465.